Adverum Biotechnologies I... (ADVM)
NASDAQ: ADVM
· Real-Time Price · USD
2.82
0.05 (1.81%)
At close: Aug 15, 2025, 3:59 PM
2.81
-0.35%
After-hours: Aug 15, 2025, 06:04 PM EDT
Adverum Biotechnologies Fail-to-Deliver
Total FTD Shares
169
Below Average
FTD / Avg. Volume
0.08%
Low Impact
1-Year Change
-80.1%
Negative Trend
FTD Chart
As of Jul 11, 2025,
Adverum Biotechnologies Inc. has
169
shares failed to deliver, representing 0.08%
of the average daily volume of
211,232
shares. Over the past year, the monthly average FTD is
8,506
shares, with the current level 98% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 11, 2025 | 2.54 | 169 | -98.16% |
| Jun 30, 2025 | 2.15 | 9.16K | +32614.29% |
| May 29, 2025 | 2.26 | 28 | -93.94% |
| Apr 28, 2025 | 2.88 | 462 | -40.92% |
| Mar 26, 2025 | 5.04 | 782 | -93.37% |
| Feb 28, 2025 | 4.71 | 11.8K | +8514.60% |
| Jan 10, 2025 | 4.27 | 137 | -84.62% |
| Dec 31, 2024 | 4.67 | 891 | +89000.00% |
| Nov 27, 2024 | 6.45 | 1 | -99.74% |
| Oct 30, 2024 | 7.88 | 386 | +7620.00% |
| Sep 30, 2024 | 7.02 | 5 | -96.69% |
| Aug 30, 2024 | 6.94 | 151 | +88.75% |
| Jul 31, 2024 | 7.42 | 80 | -4.76% |
| Jun 25, 2024 | 6.91 | 84 | -82.46% |
| May 23, 2024 | 7.83 | 479 | +7883.33% |
| Apr 24, 2024 | 10.19 | 6 | +100.00% |
| Mar 28, 2024 | 14.14 | 3 | -99.80% |
| Feb 26, 2024 | 19.5 | 1.5K | +649.50% |
| Jan 30, 2024 | 10.6 | 200 | +488.24% |
| Dec 11, 2023 | 8.31 | 34 | -98.02% |
| Nov 10, 2023 | 9.37 | 1.72K | +1901.16% |
| Oct 11, 2023 | 10 | 86 | -89.58% |
| Sep 25, 2023 | 16 | 825 | +2071.05% |
| Aug 14, 2023 | 17.9 | 38 | -97.27% |
| Jul 27, 2023 | 18.2 | 1.39K | -77.06% |
| Jun 30, 2023 | 15.9 | 6.07K | +2515.95% |
| May 31, 2023 | 12.3 | 232 | -22.67% |
| Apr 24, 2023 | 9.02 | 300 | -91.00% |
| Mar 22, 2023 | 7.8 | 3.33K | +78.04% |
| Feb 23, 2023 | 7 | 1.87K | -90.31% |
| Jan 31, 2023 | 6.51 | 19.32K | n/a |